Transcode Therapeutics | 8-K: Current report
Apr 23 16:06 ET
Transcode Therapeutics | 8-K: Current report
Apr 5 16:55 ET
Transcode Therapeutics | 10-K: Annual report
Apr 1 17:14 ET
Transcode Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Zdravka Medarova(0.4%)
Feb 15 16:03 ET
Transcode Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Tang Capital Partners, LP(0.0%),Tang Capital Management, LLC(0.0%), etc.
Feb 14 16:04 ET
Transcode Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(0.1%),Lind Global Partners II LLC(0.1%), etc.
Feb 13 20:16 ET
Transcode Therapeutics | 8-K: Current report
Jan 31 16:39 ET
Transcode Therapeutics | 8-K: Current report
Jan 22 00:00 ET
Transcode Therapeutics | 424B4: Prospectus
Jan 22 00:00 ET
Transcode Therapeutics | EFFECT: Others
Jan 19 00:00 ET
Transcode Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Jan 18 00:00 ET
Transcode Therapeutics | CORRESP: CORRESP
Jan 17 11:31 ET
Transcode Therapeutics | CORRESP: CORRESP
Jan 17 11:31 ET
Transcode Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Jan 17 00:00 ET
Transcode Therapeutics | UPLOAD: Others
Jan 16 11:31 ET
Transcode Therapeutics | 8-K: Current report
Jan 16 00:00 ET
Transcode Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Jan 11 00:00 ET
Transcode Therapeutics | 8-K: Current report
Jan 8 00:00 ET
Transcode Therapeutics | DEFA14A: Others
Jan 4 00:00 ET
Transcode Therapeutics | DEF 14A: Definitive information statements
Dec 18, 2023 16:28 ET
No Data
No Data